Kiniksa Pharmaceuticals International Plc (KNSA)
53.24
-0.41
(-0.76%)
USD |
NASDAQ |
May 22, 16:00
53.13
-0.11
(-0.21%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Free Cash Flow : 164.23M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aurinia Pharmaceuticals, Inc. | 166.93M |
| Amgen, Inc. | 8.597B |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| United Therapeutics Corp. | 1.011B |
| AbbVie, Inc. | 19.98B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 50.20M |
| Cash from Investing (Quarterly) | -31.92M |
| Cash from Financing (Quarterly) | 6.073M |
| Free Cash Flow Per Share (Quarterly) | 0.6072 |
| Free Cash Flow to Equity (Quarterly) | 50.51M |
| Free Cash Flow to Firm (Quarterly) | 50.04M |
| Free Cash Flow Yield | 3.83% |